Clinical trial registry record

Therapeutic Fasting and Immune Aging

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Not Yet Recruiting.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated April 8, 2025.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05857241
Last registry update
April 8, 2025
Status
Not Yet Recruiting
Phase
Phase not reported
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Enrollment
20
Countries
France
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Not Yet Recruiting. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
NA · SINGLE GROUP · TREATMENT · NONE
Evidence population
Human clinical study registration
Participants
20
Population
ALL · 65 Years
Duration
2025-04-01 to 2026-03-01
Intervention
Fasting mimicking diet (FMD)
Comparator
Not reported
Outcomes measured
rate of premature discontinuation of the fasting-mimicking diet — between Day 14 and Day 21; serious and non-serious adverse events reported — Between day 0 to day 42; composite outcome: evolution of biological biochemic parameters — Day 0 to Day 42; composite outcome: evolution of biological blood parameters — Day 0 to Day 42; composite outcome: evolution biological inflammatory parameters — Day 0 to Day 42
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Immune ageing · 100%Title contains controlled term: immune aging. Abstract contains controlled term: immunosenescence. Title supplies longevity context: aging. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.

immune aging
Open primary sourceExport JSON